# FDA recall D-0705-2026

> **Major Pharmaceuticals** · Class II · drug recall initiated 2026-07-13.

## Product

Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA.  NDC: 0904-6955-61

## Reason for recall

Subpotent Drug

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0705-2026
- **Recalling firm:** Major Pharmaceuticals
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-07-13
- **Report date:** 2026-07-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dublin, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0705-2026

## Citation

> AI Analytics. FDA recall D-0705-2026. Retrieved 2026-08-31 from https://api.ai-analytics.org/recall/D-0705-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*